FQCC (Fuquan Capital Management) Notes Receivable: $0.00 Mil (As of . 20)


What is Fuquan Capital Management Notes Receivable?

Fuquan Capital Management FQCC -99.00% Notes Receivable is $0.00 Mil as of . 20.

Fuquan Capital Management's Notes Receivable for the quarter that ended in . 20 was $0.00 Mil.

Fuquan Capital Management Notes Receivable Related Terms

Fuquan Capital Management Notes Receivable Historical Data

* Premium members only.

The historical data trend for Fuquan Capital Management's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuquan Capital Management Notes Receivable Chart

Fuquan Capital Management Annual Data
Trend
Notes Receivable

Fuquan Capital Management Quarterly Data
Notes Receivable

Fuquan Capital Management Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Fuquan Capital Management (FQCC) has a Notes Receivable of $0.00 Mil as of . 20. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Fuquan Capital Management and its competitors.
Is Fuquan Capital Management's Notes Receivable too high?
Fuquan Capital Management's current Notes Receivable is $0.00 Mil.
How does Fuquan Capital Management's Notes Receivable compare to DSOX and CDTI?
Fuquan Capital Management's Notes Receivable of $0.00 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for an Industrial Products company?
A good Notes Receivable depends on the Industrial Products industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Fuquan Capital Management and its competitors. Fuquan Capital Management's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuquan Capital Management stock overvalued right now?
Fuquan Capital Management (FQCC) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Fuquan Capital Management (FQCC), the current Notes Receivable is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fuquan Capital Management Business Description

Address 25 Market Street Suite, New York, NY, USA, 12601
Fuquan Capital Management Inc is a green technology company. The company is specialized in green energy audits, green engineering, design-build and life safety compliance. The company's key products include algae biomass, algae cake, astaxanthin, omega-3, and algae oil. It serves nutraceutical, pharmaceutical, and health and wellness markets.